231 results
Page 4 of 12
6-K
ujushx kuzxu
21 Dec 22
Current report (foreign)
6:01am
6-K
0u80ev qtp
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
yqvvtwtr6c2y8zlr3k
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
xqe0zxcc5kni mpgis41
8 Dec 22
Current report (foreign)
6:46am
6-K
m7iew0bl5psx3tgz
4 Nov 22
Current report (foreign)
6:01am
6-K
EX-99.1
0b2jbwcis40oze4d
27 Oct 22
Current report (foreign)
6:01am
6-K
bgre6vuaie jbzqrw
27 Oct 22
Current report (foreign)
6:01am
6-K
m56w7
14 Oct 22
Current report (foreign)
7:36am
6-K
bu8oy0hx 40bb
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
55o7fpeghm2d97
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
kho5f6odbu6enqzf9 3y
4 Aug 22
Current report (foreign)
6:07am
6-K
on0chw
4 Aug 22
Current report (foreign)
6:07am
6-K
ec90fed7
28 Jul 22
Current report (foreign)
6:09am
6-K
EX-99.1
9heboe
28 Jul 22
Current report (foreign)
6:09am
6-K
74jzrr4cfu
11 Jul 22
Current report (foreign)
6:05am
S-8
EX-99.1
e55i4
29 Jun 22
Registration of securities for employees
6:13am
6-K
682rvk uhr
29 Jun 22
Current report (foreign)
6:02am
6-K
zdzulzbue8 ce4h
24 Jun 22
Current report (foreign)
6:08am
6-K
zcv6o4p
10 Jun 22
Current report (foreign)
6:00am